FloraWorks, LLC

1 known investors

FloraWorks develops rare and novel cannabinoid-based therapeutic ingredients, focusing on non-intoxicating cannabinoids validated through peer-reviewed research and toxicology testing. It targets the health, wellness, and supplement markets, aiming to bring scientifically validated cannabinoid products to mainstream retailers.